K. Filion

First name
K.
Middle name
B.
Last name
Filion
Brunetti, V. C., H. Y. Yu, O., Platt, R. W., & Filion, K. B. (2022). The Association of Long-Acting Insulin Analogue Use Versus Neutral Protamine Hagedorn Insulin Use With Major Adverse Cardiovascular Events Among Individuals With Type 2 Diabetes: A Population-Based Cohort Study. Diabetes Obes Metab. http://doi.org/10.1111/dom.14802
Durand, M., Schnitzer, M. E., Pang, M., Carney, G., Eltonsy, S., Filion, K. B., et al. (2021). Effectiveness and safety among direct oral anticoagulants in nonvalvular atrial fibrillation: A multi-database cohort study with meta-analysis. Br J Clin Pharmacol, 87, 2589-2601. http://doi.org/10.1111/bcp.14669
Ayele, H. T., Douros, A., & Filion, K. B. (2022). 5-α reductase inhibitors and the risk of anaemia among men with benign prostatic hyperplasia: A population-based cohort study. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.15317
Filion, K. B., Delaney, J. A., Brophy, J. M., Ernst, P., & Suissa, S. (2007). The impact of over-the-counter simvastatin on the number of statin prescriptions in the United Kingdom: a view from the General Practice Research Database. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.1314
Daskalopoulou, S. S., Delaney, J. A., Filion, K. B., Brophy, J. M., Mayo, N. E., & Suissa, S. (2008). Discontinuation of statin therapy following an acute myocardial infarction: a population-based study. Eur Heart J. http://doi.org/10.1093/eurheartj/ehn346
Filion, K. B., Joseph, L., Boivin, J. F., Suissa, S., & Brophy, J. M. (2009). Trends in the prescription of anti-diabetic medications in the United Kingdom: a population-based analysis. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.1802
Azoulay, L., Schneider-Lindner, V., Dell'Aniello, S., Filion, K. B., & Suissa, S. (2010). Thiazolidinediones and the risk of incident strokes in patients with type 2 diabetes: a nested case-control study. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.1883
Filion, K. B., Joseph, L., Boivin, J. F., Suissa, S., & Brophy, J. M. (2011). Thiazolidinediones and the risk of incident congestive heart failure among patients with type 2 diabetes mellitus. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.2165
Azoulay, L., Yin, H., Filion, K. B., Assayag, J., Majdan, A., Pollak, M. N., & Suissa, S. (2012). The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study. Bmj. http://doi.org/10.1136/bmj.e3645
Filion, K. B., Chateau, D., Targownik, L. E., Gershon, A., Durand, M., Tamim, H., et al. (2014). Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis. Gut. http://doi.org/10.1136/gutjnl-2013-304738